These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2808846)

  • 61. Chronic actinic dermatitis: two patients with successful management using narrowband ultraviolet B phototherapy with systemic steroids.
    Khaled A; Kerkeni N; Baccouche D; Zeglaoui F; Kamoun MR; Fazaa B
    Therapie; 2011; 66(5):453-7. PubMed ID: 22031690
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Actinic reticuloid.
    Marx JL; Vale M; Dermer P; Ragaz A; Michaelides P; Gladstein AH
    Arch Dermatol; 1982 Sep; 118(9):672-5. PubMed ID: 7114871
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chronic actinic dermatitis: successful treatment with psoralen-ultraviolet A photochemotherapy.
    Chee SN; Novakovic L; Fassihi H; Garibaldinos T; Sarkany R
    Br J Dermatol; 2018 Mar; 178(3):e189-e190. PubMed ID: 28889653
    [No Abstract]   [Full Text] [Related]  

  • 64. The photosensitivity dermatitis and actinic reticuloid syndrome (chronic actinic dermatitis) occurring in seven young atopic dermatitis patients.
    Russell SC; Dawe RS; Collins P; Man I; Ferguson J
    Br J Dermatol; 1998 Mar; 138(3):496-501. PubMed ID: 9580807
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M; García-Arpa M; González-García J
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PUVA therapy of chronic actinic dermatitis.
    Sinclair SE; Hindson C
    Australas J Dermatol; 1988; 29(2):117-9. PubMed ID: 3269703
    [No Abstract]   [Full Text] [Related]  

  • 67. Photoaccentuated erythroderma associated with CD4+ T lymphocytopenia: successful treatment with 5-methoxypsoralen and UVA, interferon alfa-2b, and extracorporeal photopheresis.
    Wolf P; Müllegger R; Cerroni L; Aigner R; Fueger G; Höfler G; Derbaschnig J; Kerl H
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 2):291-4. PubMed ID: 8698908
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acral PUVA--induced pigmented macules.
    Cruz A; Sánchez JL
    Bol Asoc Med P R; 1990 Oct; 82(10):460-2. PubMed ID: 2080960
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Aromatic retinoid--oral photochemotherapy (RePUVA) for actinic reticuloid].
    Hunziker T; Zala L; Krebs A
    Dermatologica; 1983 Jun; 166(6):311-3. PubMed ID: 6884553
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Mycosis fungoides and lymphomatoid papulosis].
    Wallach D; Janier M; Lechanteur C; Vignon-Pennamen MD; Flageul B; Cottenot F
    Ann Dermatol Venereol; 1984; 111(8):773-4. PubMed ID: 6335634
    [No Abstract]   [Full Text] [Related]  

  • 71. Keratinocyte T6 antigen expression after PUVA therapy.
    Dreno B; Milpied B; Stalder JF; Guillet G; Litoux P
    Acta Derm Venereol; 1987; 67(5):406-10. PubMed ID: 2448991
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoides.
    Abel EA; Sendagorta E; Hoppe RT
    J Am Acad Dermatol; 1986 Jun; 14(6):1029-38. PubMed ID: 3722479
    [TBL] [Abstract][Full Text] [Related]  

  • 73. PUVA treatment in chromium hypersensitivity: effect on skin reactivity and lymphocyte functions.
    Jansén CT; Viander M; Kalimo K; Soppi AM; Soppi E
    Arch Dermatol Res; 1981; 270(3):255-61. PubMed ID: 7271310
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Normalized light reactions in mycosis fungoides patients after complete remission of skin lesions.
    Volden G
    Acta Derm Venereol; 1980; 60(2):161-63. PubMed ID: 6155026
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The risk of photochemotherapy.
    Stüttgen G
    Int J Dermatol; 1982 May; 21(4):198-202. PubMed ID: 7047417
    [No Abstract]   [Full Text] [Related]  

  • 76. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer.
    Bruynzeel I; Bergman W; Hartevelt HM; Kenter CC; Van de Velde EA; Schothorst AA; Suurmond D
    Br J Dermatol; 1991 Jan; 124(1):49-55. PubMed ID: 1993145
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PUVA lentigines confined to mycosis fungoides lesions.
    Gonzàlez-de Arriba A; Pedraz J; Jones-Caballero M; Nam-Cha T; Fernández-Herrera J; García-Diez A
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):1005-6. PubMed ID: 17659031
    [No Abstract]   [Full Text] [Related]  

  • 78. Development of new lesions: a complication of psoralen plus ultraviolet A light therapy for mycosis fungoides.
    Fernandes S; Marques Pinto G; Cardoso J
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):278-9. PubMed ID: 22971198
    [No Abstract]   [Full Text] [Related]  

  • 79. [PUVA therapy of cutaneous diseases except psoriasis (author's transl)].
    Thivolet J; Mauduit G
    Ther Umsch; 1982 Mar; 39(3):212-7. PubMed ID: 7089910
    [No Abstract]   [Full Text] [Related]  

  • 80. Follicular mycosis fungoides--augmentation by PUVA therapy.
    Germing H; Hölzle E; Schulte-Huermann P; Ruzicka T
    Acta Derm Venereol; 1995 Mar; 75(2):164-5. PubMed ID: 7604657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.